作者
Supriyo Saha
发表日期
2021/9/1
来源
Current drug targets
卷号
22
期号
12
页码范围
1437-1462
出版商
Bentham Science Publishers
简介
Background
Glycogen synthase kinase 3 (GSK-3) is a serine/threonine kinase enzyme that controls neuronal functions such as neurite outgrowth, synapse formation, neurotransmission, and neurogenesis. The enzyme has two subunits as GSK-3α and GSK-3β. 4ACC, 1Q3D, 3AFG, 1UV5, and 1Q5K are the important GSK-3 receptors isolated from Homo sapiens and Mus musculus. This enzyme mainly phosphorylates Tau protein with the increased amount in neuronal fibres together with beta-amyloid plaques that cause neuronal diseases like Alzheimer's, Parkinson’s and many more.
Objective
We investigated the developments of various synthetic GSK-3 inhibitors responsible for the prevention and treatment of neurological disorders, like Alzheimer's disease, bipolar disorders, acting as antidepressants, neuroprotective, etc.
Results and Conclusion
It has been observed that structures of the GSK-3 inhibitors are …
学术搜索中的文章
S Saha, D Pal, SB Nimse - Current Drug Targets, 2021